Although several soluble molecules and bronchoalveolar lavage fluid (BALF) marker, including CXCL11 [54], KL-6 [55], IL-7 [56], and YKL-40 [57], for IPF have been investigated, however, there is an urgent need to discover new biomarkers to predict the clinical outcome of IPF patients after lung transplantation. Here, MUC1 is linked to idiopathic pulmonary fibrosis.